Purpose of the development: POLIONK drug intended for use in medicine and has antimetastatic activity against tumors. Laboratory regulations. Temporary Pharmacopoeia article. POLIMITON drug intended for use in medicine in the treatment of certain autoimmune, immunodeficiency and infectious diseases.

Recommended application field: Medicine.

Advantages over analogues: Highly effective medicines.

The development stage readiness: Ready for application

Description of the development:
()
Drug Polionk - polysaccharide of bacterial origin with a significant antimetastatic activity against tumors. Laboratory regulations. Temporary Pharmacopoeia article. Preparation Polimiton - Polysaccharide of bacterial origin capable of selectively modulating T-and B-lymphocyte system that allows its use for treatment of certain autoimmune, immunodeficiency and infectious diseases.

Information about newness of the development:

ноу-хау--
1 шт.

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Licence's sale
Technological document's sale
Combinated reduction to industrial level
Creation of joint enterprise

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua